Notice to Market (XS3327796309, SPUK 107)

Summary by AI BETAClose X

Canadian Imperial Bank of Commerce has issued a notification correcting a manifest error in the Aggregate Nominal Amount for Series No SPUK 107, ISIN XS3327796309, which was issued on 22 May 2026. The Aggregate Nominal Amount has been corrected from €1,000,000 to €10,000,000. All other terms and conditions of the Final Terms remain unchanged, and the amended Final Terms have been submitted to the National Storage Mechanism.

Disclaimer*

Canadian Imperial Bank of Commerce
01 June 2026
 

CIBC                            CIBC CAPITAL MARKETS

NOTIFICATION OF MANIFEST ERROR CORRECTION TO THE NOTIONAL AMOUNT

 

 

RE:

Series No          ISIN                       Issue Date SPUK 107       XS3327796309       22 May 2026

 

We refer to the above issue of Notes, described in more detail in the Final Terms (the "Final Terms"), as signed by CIBC, as well as the Terms and Conditions of the Notes (the "Conditions"), which are supplemented by the Final Terms and which are set out in the Prospectus dated 23 January 2026 (the "Prospectus").

 

Correction of Manifest Error

The following changes are made to the Final Terms for a manifest error for the "Aggregate Nominal Amount". It now has been replaced as follows:-

 

On Page 1 and 2 of the Final Terms:

 




 




 

In all other respects, the Final Terms is correct and all other terms and conditions of the Final Terms remain unchanged. Capitalised terms used but not defined herein shall have the same meaning ascribed thereto in the Final Terms.

The amended Final Terms have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

For further information, please contact:

CIBC Structured Notes Execution Management (dlcibcexecutionmanagement@cibc.com) Yours faithfully,

Francois-Xavier Desplanches Head of Structured Notes

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings